Because of toxicity, its use is not advised
KPV shuts down the inflammatory program driving gut damage
When the HOPE-2 trial (51), and other major trials such as VISP and VITATOPS (52), were re-analyzed, specific subgroups were identified that were most likely to benefit from B vitamin supplementation in reducing stroke risk, including (1) adults less than 69 years of age, (2) those not exposed to folic acid fortification, (3) those with elevated homocysteine or cholesterol, and (4) those who were not taking anti-platelet or lipid-lowering drugs
2015, Sep, 18;10(9):e0138721
P16INK4a upregulation mediated by TBK1 induces retinal ganglion cell senescence in ischemic injury
Chng sn sinh ti gan v c tng hp t t bo bng 3 loi acid amin gm cysteine, glutamic v glycine